Instead of continuing to rely on trial-and-error testing, pharmaceutical scientists are increasingly turning to computer software to create better treatments.
Potential blockbuster VTAMA® (tapinarof) approved by FDA for the treatment of plaque psoriasis at end of May 2022 is the first topical novel chemical entity launched for plaque psoriasis in
Roivant Sciences (ROIV) Reports Q4 Net Loss of $291.3M, Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), today announced the appointment of Dr. Humphrey Gardner as Chief Medical Officer (CMO)..